Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Market Cap	5.59B
Revenue (ttm)	1.89B
Net Income (ttm)	-40.61M
Shares Out	9.31B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.04 (7.00%)
Ex-Dividend Date	Sep 27, 2024

Volume	16,722,900
Average Volume	21,444,990
Open	0.610
Previous Close	0.600
Day's Range	0.590 - 0.610
52-Week Range	0.495 - 1.020
Beta	0.59
RSI	48.79
Earnings Date	Mar 28, 2025

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics compreh...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,872
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0460

Financial Performance

In 2023, HKG:0460's revenue was 1.86 billion, a decrease of -14.70% compared to the previous year's 2.18 billion. Losses were -54.02 million, -97.18% less than in 2022.

Financial numbers in CNY